Addus HomeCare (NASDAQ:ADUS) Stock: Insider R Dirk Allison Sells 98,958 Shares

Addus HomeCare Corporation (NASDAQ:ADUS) CEO R. Allison sold 98,958 shares of the business’s stock in a transaction that occurred on Monday, November 9th. The stock was sold at an average price of $123.27, for a total transaction of $12,198,552.66. Following the completion of the sale, the chief executive officer owned 183,150 shares in the company, valued at $22,576,900.50. The trade was a 35.08% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Addus HomeCare Price Performance

NASDAQ:ADUS traded up $3.87 during trading hours on Tuesday, reaching $126.29. 225,844 shares of the company’s stock were exchanged, compared to its average volume of 237,872. The company has a market capitalization of $2.36 billion, a P/E ratio of 21.05, a price-to-earnings-growth ratio of 1.82 and a beta of 0.75. Addus HomeCare Corporation has a 12 month low of $87.95 and a 12 month high of $131.59. The company has a quick ratio of 1.69, a current ratio of 1.64 and a debt-to-equity ratio of 0.02. The business’s 50-day simple moving average is $117.74 and its two-hundred day simple moving average is $106.95.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings results on Tuesday, November 3rd. The company reported $1.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.79 by $0.04. The firm had revenue of $387.74 million for the quarter, compared to analyst estimates of $388.72 million. Addus HomeCare had a net margin of 7.39% and a return on equity of 10.22%. The firm’s quarterly revenue was up 7.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.56 earnings per share. Sell-side analysts expect that Addus HomeCare Corporation will post 6.34 EPS for the current fiscal year.

Institutional Trading of Addus HomeCare

Several large investors have recently added to or reduced their stakes in ADUS. Global Retirement Partners LLC boosted its holdings in Addus HomeCare by 270.4% in the third quarter. Global Retirement Partners LLC now owns 900 shares of the company’s stock worth $99,000 after purchasing an additional 657 shares in the last quarter. Hantz Financial Services Inc. lifted its position in shares of Addus HomeCare by 21.3% in the third quarter. Hantz Financial Services Inc. now owns 620 shares of the company’s stock worth $69,000 after buying an additional 109 shares during the last quarter. Russell Investments Group Ltd. lifted its position in shares of Addus HomeCare by 8.6% in the third quarter. Russell Investments Group Ltd. now owns 82,792 shares of the company’s stock worth $9,152,000 after buying an additional 6,538 shares during the last quarter. King Luther Capital Management Corp boosted its stake in shares of Addus HomeCare by 1.7% during the 3rd quarter. King Luther Capital Management Corp now owns 35,078 shares of the company’s stock worth $3,878,000 after acquiring an additional 582 shares in the last quarter. Finally, Maryland State Retirement & Pension System raised its stake in shares of Addus HomeCare by 52.5% in the 3rd quarter. Maryland State Retirement & Pension System now owns 4,037 shares of the company’s stock valued at $446,000 after acquiring an additional 1,389 shares in the last quarter. 95.35% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on ADUS shares. Citigroup downgraded Addus HomeCare from a “market outperform” rating to a “neutral” rating in a report on Monday, September 14th. Weiss Ratings raised Addus HomeCare from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, September 24th. Raymond James Financial set a $137.00 price objective on Addus HomeCare in a report on Monday, September 28th. Wall Street Zen raised shares of Addus HomeCare from a “buy” rating to a “strong-buy” rating in a research note on Saturday. Finally, Truist Financial upped their price objective on shares of Addus HomeCare from $135.00 to $148.00 and gave the company a “buy” rating in a research note on Thursday, November 5th. Seven analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $134.70.

Addus HomeCare Company Profile

Addus HomeCare Corporation provides home-based care services to older adults and people with disabilities. Its services are designed to help clients receive care at home and in other community-based settings. The company operates through personal care, hospice and home health services. Personal care includes assistance with daily activities; hospice provides end-of-life care and support; and home health offers skilled nursing and therapy services. Founded in 1979, Addus serves communities across multiple states.